Daniel G. Welch - Jun 23, 2025 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
Director
Signature
/s/ Jun Yoon, Attorney-in-Fact
Stock symbol
GPCR
Transactions as of
Jun 23, 2025
Transactions value $
$0
Form type
4
Date filed
6/25/2025, 05:45 PM
Previous filing
May 19, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WELCH DANIEL G Director C/O STRUCTURE THERAPEUTICS INC., 601 GATEWAY BLVD., SUITE 900, SOUTH SAN FRANCISCO /s/ Jun Yoon, Attorney-in-Fact 2025-06-25 0001206199

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GPCR Share Option (right to buy) Award $0 +51.8K $0.00 51.8K Jun 23, 2025 Ordinary Shares 51.8K $7.37 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").
F2 The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting,
F3 The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.